Cross-linking of hard gelatin carbamazepine capsules: Effect of dissolution conditions on in vitro drug release

European Journal of Pharmaceutical Sciences

Volumn 19, Issue 2-3, 2003, Pages 129-132

  Marchais, Hervé ^a,c   Cayzeele, Guillaume ^a   Legendre, Jean Yves ^b   Skiba, Mohamed ^a   Arnaud, Philippe ^a  

^a Faculté de Médecine Pharmacie   (France)

^b L ORÉAL RECHERCHE   (France)

^c UFR des Sciences Pharmaceutiques   (France)

Author keywords

Carbamazepine; Cross linking; Dissolution with sodium lauryl sulfate; Enzymes; Hard gelatin capsule

Indexed keywords

CROSSLINKING; DISSOLUTION; ENZYMES; FORMALDEHYDE;

SIMULATED GASTRIC FLUID (SGF);

DRUG PRODUCTS;

CARBAMAZEPINE; CONI SNAP; CROSS LINKING REAGENT; DODECYL SULFATE SODIUM; ENZYME; FORMALDEHYDE; GELATIN; PANCREATIN; PEPSIN A; SURFACTANT; UNCLASSIFIED DRUG; WATER;

ARTICLE; CHEMISTRY; CONCENTRATION (PARAMETERS); CONTROLLED DRUG RELEASE; CROSS LINKING; DRUG CAPSULE; DRUG SOLUBILITY; EXPERIMENTAL MODEL; HARDNESS; IN VITRO STUDY; INTESTINE FLUID; MICROCAPSULE; PRIORITY JOURNAL; SIMULATION; SOLUBILITY; STOMACH JUICE; STRESS;

EID: 0038182089     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(03)00070-8     Document Type: Article

References (12)

1. Brown J., Madit N., Cole E.T., Wilding I.R., Cade D. The effect of cross-linking on the in vivo disintegration of hard gelatin capsules. Pharm. Res. 15:1998;1026-1030.
2. Chafetz L., Hong W., Tsilifonis D.C., Taylor A.K., Philip J.J. Decrease in the rate of capsule dissolution due to formaldehyde from polysorbate 80 auto-oxidation. J. Pharm. Sci. 73:1984;1186-1187.
3. Digenis G.A., Gold T.B., Shah V.P. Cross-linking of gelatin capsules and its relevance to their in vitro-in vivo performance. J. Pharm. Sci. 83:1994;915-921.
4. European Pharmacopoeia, 4th Edition, 2002. Limit Tests - Formaldehyde, p. 96.
5. Guyot M., Fawaz F., Maury M. In vitro release of theophylline from cross-linked gelatin capsules. Int. J. Pharm. 144:1989;209-216.
6. Jung H., Milan R.C., Girard M.E., Leon F., Montoya M.A. Bioequivalence study of carbamazepine tablets: in vitro/in vivo correlation. Int. J. Pharm. 152:1997;37-44.
7. Meyer M.C., Straughn A.B., Mhatre R.M., Hussain A., Shah V.P., Bottom C.B., et al. The effect of gelatin cross-linking on the bioequivalence of hard and soft gelatin acetaminophen capsules. Pharm. Res. 17:2000;962-966.
8. Murthy K.S., Enders N.A., Fawzi M.B. Dissolution stability of hard-shell capsule products. Part I: The effect of exaggerated storage conditions. Pharm. Technol. 13:1989;72-86.
9. Murthy K.S., Reisch R.G., Fawzi M.B. Dissolution stability of hard-shell capsule products. Part II: The effect of dissolution test conditions on in vitro drug release. Pharm. Technol. 13:1989;53-56.
10. Shah V.P., Konecny J.J., Everett R.L., McCullough B., Noorizadeh A.C., Skelly J.P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6:1989;612-618.
11. USP24, 2001. Test Solutions, 2235-2236.
12. USP24-NF19, Supplement 4, 2001. Sect. <711> Dissolution, 3250-3252.